Physical Activity During Pregnancy in Women With Pre-existing Diabetes
PA-DIP
2 other identifiers
observational
175
0 countries
N/A
Brief Summary
Pregnancy can be more challenging for women with pre-existing (Type 1 or Type 2 diabetes) because it increases the risk of complications such as early births or babies being born larger than usual. Keeping blood sugar levels under control is very important to reduce these risks but the hormonal changes that happen during pregnancy make this harder to manage and can cause added stress for expectant mothers. There have been improvements in technology to monitor and manage blood sugar levels, however, there have not been many improvements in pregnancy outcomes in this population Physical activity and exercise during pregnancy have many benefits such as cardiovascular health and lower chance of pregnancy complications. For individuals with diabetes, physical activity can also help manage blood sugar levels and reduce insulin requirements. However, there is limited research on physical activity in women with pre-existing diabetes. This study aims to find out how physical activity levels change throughout pregnancy, and how physical activity may be linked to blood sugar levels and diabetes related mental health. To determine what needs to be improved regarding physical activity during pregnancy in diabetes, it is crucial to first understand what activity patterns women engage in throughout pregnancy. In addition, what support is needed and when, will be explored Pregnant women (aged 18years or older) with a diagnosis of type 1 or type 2 diabetes before becoming pregnant will be invited to take part. Participants will be recruited during routine clinic visits. Physical activity during pregnancy in women with pre-existing diabetes will be explored using both measurable activity data and patient experiences of being physically activity during pregnancy. Pregnant women with pre-existing diabetes will be invited to take part from early in their pregnancy. Participants will wear a wrist-based activity monitor for seven days in each trimester, complete an exercise diary and record meals through remote food photography during this time. At the end of each monitoring period, they will complete a questionnaire on diabetes-related emotional distress. Participants will share their continuous glucose monitor and insulin pump data (if applicable), with permission, through the online platforms they normally use to share data with their healthcare team. Participants will have the option to join a focus group which will be held online via a video conferencing service (e.g.Zoom). This will involve group discussions will be audio recorded, and cover topics including experiences and feelings about physical activity, and what support regarding physical activity would they find useful. There are no direct health benefits for participants, but the study may help improve future guidance and support for women with diabetes during pregnancy. This study involves minimal risks. It requires no change in usual treatment or care, no additional clinical visits over and above those routinely scheduled, and no changes in usual behaviour. Within the observational study, there is a small risk of discomfort from wearing the activity monitor for seven days, if this becomes severe irritation, the participant will be informed they can remove the monitor and contact the research team. When conducting the focus groups there is a risk that some topics may bring out discussions which are sensitive, and the potential for participants being upset by something another participant may have said. If participants feel upset by participation in the focus group, they will be made aware they can leave at any time, and participants will directed to further support if required.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 6, 2026
CompletedStudy Start
First participant enrolled
May 11, 2026
CompletedFirst Posted
Study publicly available on registry
May 12, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 24, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 24, 2027
May 12, 2026
January 1, 2026
1.1 years
February 6, 2026
May 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in moderate-to-vigorous physical activity across pregnancy
The primary outcome is the change in daily minutes of moderate-to-vigorous physical activity across pregnancy, measured using a wrist-worn GENEActiv accelerometer.
8 - 13 weeks gestation (Trimester 1), 18 - 22 weeks gestation (trimester 2), 26 - 31 weeks gestation (trimester 3)
Secondary Outcomes (4)
Adjusted association between physical activity and glucose metrics during pregnancy
8 - 13 weeks gestation (Trimester 1), 18 - 22 weeks gestation (trimester 2), 26 - 31 weeks gestation (trimester 3)
The associations between physical activity data with dietary intake
8 - 13 weeks gestation (Trimester 1), 18 - 22 weeks gestation (trimester 2), 26 - 31 weeks gestation (trimester 3)
The associations between physical activity and Problem Areas in Diabetes (PAID) responses
8 - 13 weeks gestation (Trimester 1), 18 - 22 weeks gestation (trimester 2), 26 - 31 weeks gestation (trimester 3)
Focus groups
Conducted once during pregnancy (between 8 and 31 weeks gestation)
Study Arms (2)
Pregnant women with Type 1 Diabetes
75 women with Type 1 Diabetes will be recruited to take part in the study. A subset of \~8 of these women will be invited to take part in a focus group.
Pregnant women with Type 2 Diabetes
100 women with Type 2 Diabetes will be recruited to take part in this study. A subset of \~8 of these women will be invited to take part in a focus group.
Interventions
This is an observational study, there is no intervention.
Eligibility Criteria
Eligible participants will be pregnant women with a diagnosis of T1D or T2D prior to conception.
You may qualify if:
- Women between 8 - 20 weeks pregnant (this will allow completion of at least two measures during pregnancy)
- Singleton pregnancy
- Confirmed diagnosis of T1D or T2D
- Over 18 years old
- Willing and able to provide informed consent
- Receiving care at one of the participating NHS sites
You may not qualify if:
- Multiple pregnancy
- Absolute contra-indication to PA according to 2019 Canadian Guidelines for physical activity during pregnancy , examples include ruptured membranes, preeclampsia and intrauterine growth restriction, full list available here37
- No diagnoses of T1D or T2D prior to pregnancy
- Gestational Diabetes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Rob Andrews, PhD
University of Exeter
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2026
First Posted
May 12, 2026
Study Start
May 11, 2026
Primary Completion (Estimated)
June 24, 2027
Study Completion (Estimated)
September 24, 2027
Last Updated
May 12, 2026
Record last verified: 2026-01